A guide for weighing care
Note who does what in physician-led peptide care.
Peptides have a short chain shape. They contain a few of the same small parts found in proteins. The medicine insulin belongs to this group.
Ask who will assess you, why a medicine is being offered and who will answer later. Keep the answers together before you decide.
Open the care checklist
A doctor and a medicine are separate questions
Physician means doctor. Ask what “physician-led” means in the service you are considering. Will a doctor assess you? Does a doctor oversee someone else? Who makes the decision about a prescription?
The same question sheet can travel to an office visit or an online appointment.
Words used on this sheet
- Peptide
- Peptides have a short chain shape. They contain a few of the same small parts found in proteins. The medicine insulin belongs to this group.
- Telehealth
- Telehealth means a health visit by phone, video or written answers online.
- Compounding
- Compounding makes a patient’s medicine by preparing or mixing it, rather than supplying a finished factory product.
- Prescriber
- Whoever writes the medicine order.
Which kind of medicine is being offered?
The Food and Drug Administration goes by the shorter name FDA.
By September 26, 2026, semaglutide (Ozempic, Wegovy) had FDA approval.
For an adult with type 2 diabetes, Ozempic can help control blood sugar. Wegovy is used to lose weight and help stop it coming back.
Both are used alongside changes to food and exercise.
For approval, the FDA reviews a medicine’s safety and whether it works for a specific use.
US law allows compounding when its conditions are met, but these medicines have no FDA approval (September 26, 2026).
Sometimes an approved product is unavailable or does not meet the patient’s need; the FDA says compounding may help then (September 26, 2026).
There is no FDA check of how well a compounded product was made, its safety or whether it works before sale (September 26, 2026).
Get the full product name. Ask whether it has FDA approval or was made to order. “Peptide” alone does not answer that question.
For that medicine, ask both the pharmacy and prescriber: “Why do I need this rather than an approved product? Is the ingredient allowed for this use? Please explain the law that permits this exact medicine.”
Collect the names and the plan
Tick a line after you have an answer. An empty box is room for another question.
Pause for an answer to these claims
A treatment menu with no assessment
The Federation of State Medical Boards’ guidance rejects prescribing just because a patient picked something from a menu (September 26, 2026).
The same advice says you must have a way to question your doctor or another health professional about later care.
State boards may use that advice; the rules each state makes are the ones with legal force.
Approval claims for a compounded product
Calling a compounded medicine “FDA approved” is misleading, the FDA says (September 26, 2026).
Study labels on products offered as treatment
A weight-loss product may carry “for research purposes” on its label while being sold with directions for people. Another label in these offers is “not for human consumption.” The FDA warns against these offers (September 26, 2026).
In everyday words, they say “not for people to take” or “for study.”
The FDA warns of possible harm to health from these products and says their quality is not known.
Open the record behind the answer
- Choose a medical board
This directory points to the state boards that publish doctors’ licence records and public board actions.
- Look up the pharmacy
Pick a state on this FDA page to reach its pharmacy licence records. A pharmacy licence does not prove that the pharmacy is supplying medicines properly. Ask the pharmacy how it checks your prescription and where it gets the medicine.
- Learn what compounding changes
The FDA explains medicines made for a patient. Keep a question beside that reading: why is the prescriber offering one to me?